Prodotto aggiunto correttamente al carrello.

Adenosine, cyclic 3',5'-(hydrogen phosphate)
Visualizzare in 3D

Indagoo logo

Adenosine, cyclic 3',5'-(hydrogen phosphate)

CAS: 60-92-4

Rif. AN-AG00IAN5

1g
Fuori produzione
5g
Fuori produzione
25g
Fuori produzione
250mg
Fuori produzione

Prodotto fuori produzione. Per informazioni su prodotti simili, compilare il nostro modulo di richiesta o inviarci un'e-mail a .


Informazioni sul prodotto

Nome:
Adenosine, cyclic 3',5'-(hydrogen phosphate)
Sinonimi:
  • [u"3',5'-Monophosphate, Adenosine Cyclic", u"Adenosine Cyclic 3',5' Monophosphate", u"Adenosine Cyclic 3',5'-Monophosphate", u'Adenosine Cyclic 3,5 Monophosphate', u'Adenosine Cyclic Monophosphate', u"Adenosine Cyclic-3',5'-Monophosphate", u'AMP, Cyclic', u"Cyclic 3',5'-Monophosphate, Adenosine", u'Cyclic AMP', u'Cyclic AMP, (R)-Isomer', u'Cyclic AMP, Disodium Salt', u'Cyclic AMP, Monoammonium Salt', u'Cyclic AMP, Monopotassium Salt', u'Cyclic AMP, Monosodium Salt', u'Cyclic AMP, Sodium Salt', u'Cyclic Monophosphate, Adenosine', u"Cyclic-3',5'-Monophosphate, Adenosine", u'Monophosphate, Adenosine Cyclic', u'cAMP', u'Cyclic AMP', u'60-92-4', u"Adenosine 3',5'-cyclic monophosphate", u"3',5'-cyclic AMP", u"Adenosine 3',5'-phosphate", u"Adenosine 3',5'-cyclophosphate", u"cyclic 3',5'-AMP", u'Adenosine cyclic monophosphate', u"cyclic 3',5'-Adenylic acid", u"Adenosine 3',5'-monophosphate", u"Adenosine-3',5'-cyclophosphate", u"cyclic Adenosine 3',5'-phosphate", u'Cyclic Adenosine Monophosphate', u'Cyclic adenylic acid', u"Adenosine cyclic 3',5'-monophosphate", u"3',5'-AMP", u"cyclic Adenosine 3',5'-monophosphate", u"Adenosine cyclic 3',5'-phosphate", u"adenosine-3',5'-cyclic-monophosphate", u'CCRIS 4291', u'Adenosine cyclophosphate', u'[3H]cAMP', u"Adenosine 3',5'-cyclic phosphate", u'[3H]-cAMP', u'UNII-E0399OZS9N', u'NSC 94017', u'Acrasin', u"Adenosine 3',5'-phosphate monohydrate", u'BRN 0052645', u'CHEBI:17489', u'Adenosine cyclicphosphate', u'EINECS 200-492-9', u'CHEMBL316966', u'E0399OZS9N', u'IVOMOUWHDPKRLL-KQYNXXCUSA-N', u'MFCD00005845', u'NCGC00093588-03', u"Adenosine 3,5'-cyclic monophosphoric acid", u'DSSTox_CID_20436', u'DSSTox_RID_79492', u'DSSTox_GSID_40436', u'adenosine-cyclic-phosphate', u"3',5'-cAMP", u'adenosine cyclic-monophosphate', u'adenosine-cyclic-phosphoric-acid', u'(4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol', u"Adenosine 3',5'-cyclic monophosphate, 99+%", u"adenosine-3',5'-cyclic monophosphate", u"Adenosine-3',5'-cyclic phosphate", u'C10H12N5O6P', u"Adenosine 3'-,5'-cyclic monophosphate", u'CAS-60-92-4', u'6-(6-Amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide', u'AK-93426', u'IUUO>>.AxEao yen', u"3'5'-cyclic AMP", u'CYCLIC AMP; CAMP', u"Cyclic 3',5'-adenylate", u'bmse000071', u'Epitope ID:137352', u'AC1L1LR0', u'SCHEMBL1244', u'Adenosini Cycloghosghas,(S)', u'Lopac0_000084', u'4-26-00-03618 (Beilstein Handbook Reference)', u"3' 5'-adenosine monophosphate", u'GTPL2352', u'GTPL5096', u"cAMP; 3',5'-Cyclic AMP", u'DTXSID8040436', u'BDBM10851', u'cid_23902375', u'HMS3260A10', u'HY-B1511', u'ZINC3873977', u'Tox21_113510', u'Tox21_500084', u"Adenosine-3',5'-cyclicmonophosphate", u'BDBM50384264', u"Adenosine 3',5'-cyclophosphoric acid", u"Adenosine 3':5'-cyclic monophosphate", u"Adenosine 3,5'-cyclic monophosphorate", u'AKOS015999561', u'Tox21_113510_1', u"3', 5'-cyclic adenosine monophosphate", u"adenosine 3',5'-(hydrogen phosphate)", u'CCG-204179', u'DB02527', u'LP00084', u'Adenosine 3a(2),5a(2)-cyclophosphate', u'NCGC00093588-01', u'NCGC00093588-02', u'NCGC00093588-04']
  • (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide
  • (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide
  • 3',5'-Amp
  • 3',5'-Cyclic adenylic acid
  • 3',5'-Fosfato De Adenosina Monohidrato
  • 3',5'-Phosphate d'adenosine monohydrate
  • 3'-5' Cyclic Adenosine Monophosphate
  • 3′,5′-Amp
  • 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, adenosine deriv.
  • Vedi altri sinonimi
  • 5'-Cyclic Monophosphate
  • AMPc
  • Adenosin-3',5'-phosphatmonohydrat
  • Adenosine 3',5'-Phosphate Monohydrate
  • Adenosine 3',5'-cyclic monophosphate
  • Adenosine 3',5'-cyclic phosphate
  • Adenosine 3',5'-cyclophosphate
  • Adenosine 3',5'-monophosphate
  • Adenosine 3',5'-phosphate
  • Adenosine 3′,5′-cyclic phosphate
  • Adenosine 3′,5′-cyclophosphate
  • Adenosine 3′,5′-monophosphate
  • Adenosine 3′,5′-phosphate
  • Adenosine cyclic 3',5'-monophosphate
  • Adenosine cyclic 3′,5′-monophosphate
  • Adenosine cyclic monophosphate
  • Adenosine, cyclic 3′,5′-(hydrogen phosphate)
  • Camp
  • Cyclic 3',5'-AMP
  • Cyclic 3',5'-adenylic acid
  • Cyclic 3′,5′-AMP
  • Cyclic 3′,5′-adenylic acid
  • Cyclic 3′,5′-monophosphate adenosine
  • Cyclic Amp
  • Cyclic adenosine 3',5'-monophosphate
  • Cyclic adenosine 3',5'-phosphate
  • Cyclic adenosine 3′,5′-monophosphate
  • Cyclic adenosine 3′,5′-phosphate
  • Cyclic-3′,5′-phosphate adenosine
  • Nqz-026
  • Nsc 143670
  • Nsc 94017
Marchio:
Indagoo
Conservazione lunga:
Note:

Proprietà chimiche

Peso molecolare:
329.2059
Formula:
C10H12N5O6P
Purezza:
99%
Colore/Forma:
Solid
InChI:
InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
InChI key:
IVOMOUWHDPKRLL-KQYNXXCUSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta di informazioni sul prodotto fuori produzione: AN-AG00IAN5 Adenosine, cyclic 3',5'-(hydrogen phosphate)

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".